Clinical Trials Browser

Phase 2 × Neuroendocrine Tumors × avelumab × Clear all

NCT04291885 2025-04-03

I-MAT

Phase 2 Active not recruiting

DermatologicEndocrineNET

Carcinoma, Merkel Cell, Neuroendocrine Tumors

NCT03278379 2024-12-24

NET-002

Phase 2 Completed

Neuroendocrine Tumors

NCT03352934 2022-02-25

AveNEC

Phase 2 Completed

Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors